FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 64 filers reported holding FOGHORN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,965 | -29.0% | 9,993 | 0.0% | 0.00% | – |
| Q2 2023 | $70,351 | -12.6% | 9,993 | -23.0% | 0.00% | – |
| Q1 2023 | $80,470 | +46.0% | 12,979 | +50.2% | 0.00% | – |
| Q4 2022 | $55,117 | -24.5% | 8,639 | +1.6% | 0.00% | – |
| Q3 2022 | $73,000 | -45.5% | 8,503 | -13.7% | 0.00% | – |
| Q2 2022 | $134,000 | -17.3% | 9,848 | -7.3% | 0.00% | – |
| Q1 2022 | $162,000 | -40.4% | 10,627 | -10.6% | 0.00% | – |
| Q4 2021 | $272,000 | -79.4% | 11,885 | -87.5% | 0.00% | -100.0% |
| Q3 2021 | $1,323,000 | -34.4% | 94,940 | -49.8% | 0.00% | 0.0% |
| Q2 2021 | $2,018,000 | -31.3% | 189,109 | -15.2% | 0.00% | -50.0% |
| Q1 2021 | $2,938,000 | +2780.4% | 222,914 | +4317.6% | 0.00% | – |
| Q4 2020 | $102,000 | – | 5,046 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,674,120 | $63,370,600 | 4.60% |
| Euclidean Capital LLC | 3,147,522 | $15,737,610 | 1.72% |
| Birchview Capital, LP | 264,843 | $1,324,215 | 1.13% |
| Artal Group S.A. | 1,720,720 | $8,604 | 0.37% |
| Rockwood Wealth Management, LLC | 214,677 | $1,073,385 | 0.18% |
| Alphabet Inc. | 500,901 | $2,504,505 | 0.16% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 777,525 | $3,887,625 | 0.09% |
| CORNERCAP INVESTMENT COUNSEL INC | 25,819 | $129,095 | 0.02% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 343,720 | $1,718,600 | 0.02% |
| WADE G W & INC | 107,770 | $539 | 0.02% |